Discount Certificates Finder
Your selection:
18 Results
| MM0876 |  | Vertex Pharmaceuticals Inc./Discount/300/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 38.312% | 2.226% | 2.226% | - | 300.000 | 12/28/2026 | Morgan Stanley | |
| MM0877 | | Vertex Pharmaceuticals Inc./Discount/400/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 19.881% | 8.839% | 8.839% | - | 400.000 | 12/28/2026 | Morgan Stanley | |
| MM0878 | | Vertex Pharmaceuticals Inc./Discount/500/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 6.677% | 27.283% | 17.411% | - | 500.000 | 12/28/2026 | Morgan Stanley | |
| MM3494 | | Vertex Pharmaceuticals Inc./Discount/200/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 58.524% | 0.030% | 0.030% | - | 200.000 | 12/28/2026 | Morgan Stanley | |
| MM3496 | | Vertex Pharmaceuticals Inc./Discount/250/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 48.243% | 0.620% | 0.620% | - | 250.000 | 12/28/2026 | Morgan Stanley | |
| MM3497 | | Vertex Pharmaceuticals Inc./Discount/350/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 28.721% | 4.680% | 4.680% | - | 350.000 | 12/28/2026 | Morgan Stanley | |
| MM84YE | | Vertex Pharmaceuticals Inc./Discount/300/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 37.787% | 0.084% | 0.084% | - | 300.000 | 09/25/2026 | Morgan Stanley | |
| MM84YF | | Vertex Pharmaceuticals Inc./Discount/400/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 17.761% | 5.438% | 5.438% | - | 400.000 | 09/25/2026 | Morgan Stanley | |
| MM84YG | | Vertex Pharmaceuticals Inc./Discount/500/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 3.427% | 45.920% | 21.956% | - | 500.000 | 09/25/2026 | Morgan Stanley | |
| MN0DBU | | Vertex Pharmaceuticals Inc./Discount/300/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 40.255% | 4.562% | 4.562% | - | 300.000 | 06/24/2027 | Morgan Stanley | |
| MN0DBV | | Vertex Pharmaceuticals Inc./Discount/400/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 23.936% | 10.067% | 10.067% | - | 400.000 | 06/24/2027 | Morgan Stanley | |
| MN0DBW | | Vertex Pharmaceuticals Inc./Discount/500/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 11.670% | 19.296% | 14.569% | - | 500.000 | 06/24/2027 | Morgan Stanley | |
| MN70HZ | | Vertex Pharmaceuticals Inc./Discount/300/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 39.336% | 3.992% | 3.992% | - | 300.000 | 03/30/2027 | Morgan Stanley | |
| MN70J0 | | Vertex Pharmaceuticals Inc./Discount/400/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 22.252% | 10.286% | 10.286% | - | 400.000 | 03/30/2027 | Morgan Stanley | |
| MN70J1 | | Vertex Pharmaceuticals Inc./Discount/500/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 9.746% | 22.708% | 16.354% | - | 500.000 | 03/30/2027 | Morgan Stanley | |
| MR3W42 | | Vertex Pharmaceuticals Inc./Discount/400/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 26.350% | 8.851% | 8.851% | - | 400.000 | 12/24/2027 | Morgan Stanley | |
| MR3W43 | | Vertex Pharmaceuticals Inc./Discount/500/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 14.582% | 14.833% | 11.842% | - | 500.000 | 12/24/2027 | Morgan Stanley | |
| MR3WS2 | | Vertex Pharmaceuticals Inc./Discount/300/Call/MS | - | - | Vertex Pharmaceuticals Inc. | 41.608% | 4.651% | 4.651% | - | 300.000 | 12/24/2027 | Morgan Stanley |